Dr Bolte currently serves as the Vice-Chair of the Board of Directors at the University Hospital Basel (USB), one of the world’s leading hospitals embedded in Europe’s eminent life-sciences hub; he is a member of the “Digitalization” as well as the “Research & Education” committee.
As a public servant for more than 12 years Dr Bolte helped to shape Swissmedic’s role as an internationally respected “first-wave” reference agency as their Chief Medical Officer, previously Head of Marketing Authorization and Clinical Assessment as well as deputy Chief Executive. Swissmedic is a founding member of the Access Consortium (Australia's TGA, Health Canada, Singapore's HSA, the UK’s MHRA), also a Project Orbis Partner for the concurrent review of Oncology products coordinated by the US FDA.
Prior to that, Dr Bolte had roles of increasing responsibilities with research-based international pharmaceutical, biotech and medical device organisations (UK, USA, CH). Dr Bolte trained as a General Surgeon and had international clinical and academic appointments in Trauma, Transplant and Oncologic Surgery